Related Experiment Video
Updated: Jul 16, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human
Paulina Kober1, Beata Joanna Mossakowska1, Natalia Rusetska2
1Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Abstract:
Meningiomas are common intracranial tumors in adults. Abnormal microRNA (miRNA) expression plays a role in their pathogenesis. Change in miRNA expression level can be caused by impaired epigenetic regulation of miRNA-encoding genes. We found the genomic region covering the MIR193B gene to be DNA hypermethylated in meningiomas based on analysis of genome-wide methylation (HumanMethylation450K Illumina arrays). Hypermethylation of MIR193B was also confirmed via bisulfite pyrosequencing. Both hsa-miR-193b-3p and hsa-miR-193b-5p are downregulated in meningiomas. Lower expression of hsa-miR-193b-3p and higher MIR193B methylation was observed in World Health Organization (WHO) grade (G) II/III tumors as compared to GI meningiomas. CCND1 mRNA was identified as a target of hsa-miR-193b-3p as further validated using luciferase reporter assay in IOMM-Lee meningioma cells. IOMM-Lee cells transfected with hsa-miR-193b-3p mimic showed a decreased cyclin D1 level and lower cell viability and proliferation, confirming the suppressive nature of this miRNA. Cyclin D1 protein expression (immunoreactivity) was higher in atypical than in benign meningiomas, accordingly to observations of lower hsa-miR-193b-3p levels in GII tumors. The commonly observed hypermethylation of MIR193B in meningiomas apparently contributes to the downregulation of hsa-miR-193b-3p. Since hsa-miR-193b-3p regulates proliferation of meningioma cells through negative regulation of cyclin D1 expression, it seems to be an important tumor suppressor in meningiomas.
Insights
DNA hypermethylation of the MIR193B gene causes downregulation of hsa-miR-193b-3p in meningiomas. This microRNA acts as a tumor suppressor by inhibiting cyclin D1, thus reducing cell proliferation.
Area of Science:
- Neuro-oncology
- Epigenetics
- Molecular Biology
Background:
- Meningiomas are common adult intracranial tumors with pathogenesis influenced by abnormal microRNA (miRNA) expression.
- Epigenetic dysregulation, specifically DNA methylation, can alter miRNA levels in tumors.
- The role of MIR193B and its encoded miRNAs in meningioma development requires further elucidation.
Purpose of the Study:
- To investigate the epigenetic regulation of MIR193B in meningiomas.
- To determine the expression levels of hsa-miR-193b in relation to meningioma grade.
- To identify the functional role of hsa-miR-193b in meningioma cell proliferation.
Main Methods:
- Genome-wide methylation analysis using HumanMethylation450K Illumina arrays.
- Bisulfite pyrosequencing for targeted MIR193B methylation analysis.
- Quantitative real-time PCR for miRNA and mRNA expression analysis.
- Luciferase reporter assay and cell viability assays in meningioma cell lines.
Main Results:
- The genomic region of MIR193B was found to be hypermethylated in meningiomas.
- Both hsa-miR-193b-3p and hsa-miR-193b-5p were downregulated in meningiomas, with lower hsa-miR-193b-3p expression and higher MIR193B methylation in higher-grade tumors (WHO GII/III).
- hsa-miR-193b-3p directly targets CCND1 mRNA, and its overexpression suppressed meningioma cell viability and proliferation.
Conclusions:
- MIR193B hypermethylation contributes to hsa-miR-193b-3p downregulation in meningiomas.
- hsa-miR-193b-3p acts as a tumor suppressor by negatively regulating cyclin D1 expression and cell proliferation.
- hsa-miR-193b-3p represents a potential therapeutic target for meningioma treatment.
More Related Videos
07:26Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...